620 related articles for article (PubMed ID: 33346462)
1. [European Registry on the management of Helicobacter pylori infection: features of diagnosis and treatment in Kazan].
Abdulkhakov SR; Bordin DS; Abdulkhakov RA; Safina DD; Gizdatullina AR; Gimadieva LZ; Safina GM; Ziyatdinov AI; Maturina AM; Nyssen OP; Megraud F; O'Morain C; Perez-Gisbert J
Ter Arkh; 2020 Sep; 92(8):52-59. PubMed ID: 33346462
[TBL] [Abstract][Full Text] [Related]
2. [European registry on Helicobacter pylori management (Hp-EuReg) as a tool to evaluate and improve clinical practice in Moscow].
Bordin DS; Voynovan IN; Embutnieks YV; Nyssen OP; Megraud F; O Morain C; Perez-Gisbert J
Ter Arkh; 2020 Apr; 92(2):12-18. PubMed ID: 32598712
[TBL] [Abstract][Full Text] [Related]
3. [Effectiveness of empirical
Bordin DS; Voynovan IN; Sarsenbaeva AS; Zaytsev OV; Abdulkhakov RA; Bakulina NV; Bakulin IG; Osipenko MF; Livzan MA; Alekseenko SA; Tarasova LV; Tarasova GN; Bogomolov PO; Maev IV; Andreev DN; Abdulkhakov SR; Starostin BD; Bakanova NV; Kononova AG; Kolbasnikov SV; Bueverova EL; Moreira L; Megraud F; O'Morain C; Perez Nyssen O; Gisbert J
Ter Arkh; 2023 Mar; 95(2):120-129. PubMed ID: 37167127
[TBL] [Abstract][Full Text] [Related]
4. European Registry on the management of Helicobacter pylori infection (Hp-EuReg): analysis of 2360 patients receiving first-line therapy in Russia.
Bordin DS; Embutnieks YV; Vologzhanina LG; Il'chishina TA; Voinovan IN; Sarsenbaeva AS; Alekseenko SA; Zaitsev OV; Abdulkhakov RA; Osipenko MF; Livzan MA; Tsukanov VV; Burkov SG; Bakulina NV; Dekhnich NN; Tarasova LV; Plotnikova EY; Maev IV; Kucheryavyi YA; Baryshnikova NV; Butov MA; Kolbasnikov SV; Pakhomova AL; Zhestkova TV; Baranovskii AY; Abdulkhakov SR; Ageeva EA; Lyalyukova EA; Vasyutin AV; Golubev NN; Savilova IV; Morkovkina LV; Kononova AG; Megraud F; O'Morain C; Ramas M; Nyssen OP; McNicholl AG; Gisbert JP
Ter Arkh; 2018 Feb; 90(2):35-42. PubMed ID: 30701770
[TBL] [Abstract][Full Text] [Related]
5. Role of proton pump inhibitors dosage and duration in Helicobacter pylori eradication treatment: Results from the European Registry on H. pylori management.
Pabón-Carrasco M; Keco-Huerga A; Castro-Fernández M; Saracino IM; Fiorini G; Vaira D; Pérez-Aísa Á; Tepes B; Jonaitis L; Voynovan I; Lucendo AJ; Lanas Á; Martínez-Domínguez SJ; Almajano EA; Rodrigo L; Vologzanina L; Brglez Jurecic N; Denkovski M; Bujanda L; Abdulkhakov RA; Huguet JM; Fernández-Salazar L; Alcaide N; Velayos B; Silkanovna Sarsenbaeva A; Zaytsev O; Ilchishina T; Barrio J; Bakulin I; Perona M; Alekseenko S; Romano M; Gravina AG; Núñez Ó; Gómez Rodríguez BJ; Ledro-Cano D; Pellicano R; Bogomolov P; Domínguez-Cajal M; Almela P; Gomez-Camarero J; Bordin DS; Gasbarrini A; Kupčinskas J; Cano-Català A; Moreira L; Nyssen OP; Mégraud F; O'Morain C; Gisbert JP;
United European Gastroenterol J; 2024 Feb; 12(1):122-138. PubMed ID: 38050339
[TBL] [Abstract][Full Text] [Related]
6. Current Trends in the Management of Helicobacter pylori Infection in Serbia: Preliminary Results from the European Registry on H. pylori Management.
Milivojevic V; Babic I; Kekic D; Rankovic I; Sagdati S; Panic N; Spasic IS; Krstic M; Milosavljevic T; Moreira L; Nyssen OP; Mégraud F; O' Morain C; Gisbert J
Dig Dis; 2023; 41(3):377-386. PubMed ID: 37253341
[TBL] [Abstract][Full Text] [Related]
7. Helicobacter pylori Eradication Rates in Slovenia in the Period from 2017 to 2019: Data from the European Registry on H. pylori Management.
Tepes B; Brglez Jurecic N; Tepes K; Espada Sanchez M; Perez Nyssen O; O'Morain C; Mégraud F; Gisbert J
Dig Dis; 2021; 39(4):318-324. PubMed ID: 33099549
[TBL] [Abstract][Full Text] [Related]
8. Optimum duration of regimens for Helicobacter pylori eradication.
Yuan Y; Ford AC; Khan KJ; Gisbert JP; Forman D; Leontiadis GI; Tse F; Calvet X; Fallone C; Fischbach L; Oderda G; Bazzoli F; Moayyedi P
Cochrane Database Syst Rev; 2013 Dec; (12):CD008337. PubMed ID: 24338763
[TBL] [Abstract][Full Text] [Related]
9. [European registry Helicobacter pylori (Hp-EuReg): how has clinical practice changed in Russia from 2013 to 2018 years].
Bordin DS; Embutnieks YV; Vologzhanina LG; Ilchishina TA; Voynovan IN; Sarsenbaeva AS; Zaitsev OV; Alekseenko SA; Abdulkhakov RA; Dehnich NN; Osipenko MF; Livzan MA; Tsukanov VV; Burkov SG; Bakulina NV; Plotnikova EY; Tarasova LV; Maev IV; Kucheryavyi YA; Baryshnikova NV; Butov MA; Kolbasnikov SV; Pakhomova AL; Zhestkova TV; Baranovsky AY; Abdulhakov SR; Ageeva EA; Lyalyukova EA; Vasyutin AV; Golubev NN; Savilova IV; Morkovkina LV; Kononova AG; Megraud F; O'Morain C; Ramas M; Nyssen OP; McNicholl AG; Gisbert JP
Ter Arkh; 2019 Feb; 91(2):16-24. PubMed ID: 32598623
[TBL] [Abstract][Full Text] [Related]
10. Treatment options for Helicobacter pylori infection when proton pump inhibitor-based triple therapy fails in clinical practice.
Lee JM; Breslin NP; Hyde DK; Buckley MJ; O'Morain CA
Aliment Pharmacol Ther; 1999 Apr; 13(4):489-96. PubMed ID: 10215733
[TBL] [Abstract][Full Text] [Related]
11. Empirical Second-Line Therapy in 5000 Patients of the European Registry on Helicobacter pylori Management (Hp-EuReg).
Nyssen OP; Vaira D; Pérez Aísa Á; Rodrigo L; Castro-Fernandez M; Jonaitis L; Tepes B; Vologzhanina L; Caldas M; Lanas A; Lucendo AJ; Bujanda L; Ortuño J; Barrio J; Huguet JM; Voynovan I; Lasala JP; Sarsenbaeva AS; Fernandez-Salazar L; Molina-Infante J; Jurecic NB; Areia M; Gasbarrini A; Kupčinskas J; Bordin D; Marcos-Pinto R; Lerang F; Leja M; Buzas GM; Niv Y; Rokkas T; Phull P; Smith S; Shvets O; Venerito M; Milivojevic V; Simsek I; Lamy V; Bytzer P; Boyanova L; Kunovský L; Beglinger C; Doulberis M; Marlicz W; Goldis A; Tonkić A; Capelle L; Puig I; Megraud F; Morain CO; Gisbert JP;
Clin Gastroenterol Hepatol; 2022 Oct; 20(10):2243-2257. PubMed ID: 34954341
[TBL] [Abstract][Full Text] [Related]
12. Concomitant, bismuth quadruple, and 14-day triple therapy in the first-line treatment of Helicobacter pylori: a multicentre, open-label, randomised trial.
Liou JM; Fang YJ; Chen CC; Bair MJ; Chang CY; Lee YC; Chen MJ; Chen CC; Tseng CH; Hsu YC; Lee JY; Yang TH; Luo JC; Chang CC; Chen CY; Chen PY; Shun CT; Hsu WF; Hu WH; Chen YN; Sheu BS; Lin JT; Wu JY; El-Omar EM; Wu MS;
Lancet; 2016 Nov; 388(10058):2355-2365. PubMed ID: 27769562
[TBL] [Abstract][Full Text] [Related]
13. Combination of Bismuth and Standard Triple Therapy Eradicates Helicobacter pylori Infection in More than 90% of Patients.
McNicholl AG; Bordin DS; Lucendo A; Fadeenko G; Fernandez MC; Voynovan I; Zakharova NV; Sarsenbaeva AS; Bujanda L; Perez-Aisa Á; Vologzhanina L; Zaytsev O; Ilchishina T; Coba C; Lasala JP; Alekseenko S; Modolell I; Molina-Infante J; Ruiz-Zorrilla Lopez R; Alonso-Galan H; Moreno NF; Hinojosa J; Santaella I; Varela P; Gonzalez-Cordero PL; Barrio J; Dominguez-Jimenez JL; Nuñez O; Alcedo J; Nyssen OP; Caldas M; Donday MG; Shvetz O; Megraud F; O'Morain C; Gisbert JP
Clin Gastroenterol Hepatol; 2020 Jan; 18(1):89-98. PubMed ID: 30978536
[TBL] [Abstract][Full Text] [Related]
14. [European Registry on the management of Helicobacter pylori infection (Hp-EuReg protocol): The first results of Russian centers].
Bordin DS; Yanova OB; Abdulkhakov RA; Tsukanov VV; Livzan MA; Burkov SG; Zakharova NV; Plotnikova EY; Osipenko MF; Tarasova LV; Maev IV; Kucheryavyi YA; Butov MA; Sablin OA; Kolbasnikov SV; Voinovan IN; Abdulkhakov SR; Vasyutin AV; Lyalyukova EA; Golubev NN; Savilova IV; Grigoryeva LV; Kononova AG; O'Morain C; Ramas M; Mcnicholl AG; Gisbert JP
Ter Arkh; 2016; 88(2):33-38. PubMed ID: 27030181
[TBL] [Abstract][Full Text] [Related]
15. Clarithromycin resistance and female gender affect Helicobacter pylori eradication failure in chronic gastritis.
Chang YW; Ko WJ; Oh CH; Park YM; Oh SJ; Moon JR; Cho JH; Kim JW; Jang JY
Korean J Intern Med; 2019 Sep; 34(5):1022-1029. PubMed ID: 29898576
[TBL] [Abstract][Full Text] [Related]
16. European Registry on
Nyssen OP; Bordin D; Tepes B; Pérez-Aisa Á; Vaira D; Caldas M; Bujanda L; Castro-Fernandez M; Lerang F; Leja M; Rodrigo L; Rokkas T; Kupcinskas L; Pérez-Lasala J; Jonaitis L; Shvets O; Gasbarrini A; Simsek H; Axon ATR; Buzás G; Machado JC; Niv Y; Boyanova L; Goldis A; Lamy V; Tonkic A; Przytulski K; Beglinger C; Venerito M; Bytzer P; Capelle L; Milosavljević T; Milivojevic V; Veijola L; Molina-Infante J; Vologzhanina L; Fadeenko G; Ariño I; Fiorini G; Garre A; Garrido J; F Pérez C; Puig I; Heluwaert F; Megraud F; O'Morain C; Gisbert JP;
Gut; 2021 Jan; 70(1):40-54. PubMed ID: 32958544
[TBL] [Abstract][Full Text] [Related]
17. Concomitant therapy achieved the best eradication rate for Helicobacter pylori among various treatment strategies.
Lee HJ; Kim JI; Lee JS; Jun EJ; Oh JH; Cheung DY; Chung WC; Kim BW; Kim SS
World J Gastroenterol; 2015 Jan; 21(1):351-9. PubMed ID: 25574111
[TBL] [Abstract][Full Text] [Related]
18. Ranitidine bismuth citrate-based triple therapies as a second-line therapy for Helicobacter pylori in Turkish patients.
Köksal AS; Parlak E; Filik L; Yolcu OF; Odemiş B; Ulker A; Saşmaz N; Ozden A; Sahin B
J Gastroenterol Hepatol; 2005 Apr; 20(4):637-42. PubMed ID: 15836716
[TBL] [Abstract][Full Text] [Related]
19. [Eradication of Helicobacter pylori infection in Europe: a meta-analysis based on congress abstracts, 1997-2002].
Buzás GM; Józan J
Orv Hetil; 2004 Oct; 145(40):2035-41. PubMed ID: 15559530
[TBL] [Abstract][Full Text] [Related]
20. Standard triple therapy in Helicobacter pylori eradication in Turkey: Systematic evaluation and meta-analysis of 10-year studies.
Sezgin O; Aydın MK; Özdemir AA; Kanık AE
Turk J Gastroenterol; 2019 May; 30(5):420-435. PubMed ID: 31060997
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
